Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors

Thumbnail
View/Open
Published version (300.1Kb)
Date
2001-04-24
ICR Author
Kelland, Lloyd
Neidle, Stephen
Author
Read, M
Harrison, RJ
Romagnoli, B
Tanious, FA
Gowan, SH
Reszka, AP
Wilson, WD
Kelland, LR
Neidle, S
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
The telomerase enzyme is a potential therapeutic target in many human cancers. A series of potent inhibitors has been designed by computer modeling, which exploit the unique structural features of quadruplex DNA, These 3,6,9-trisubstituted acridine inhibitors are predicted to interact selectively with the human DNA quadruplex structure, as a means of specifically inhibiting the action of human telomerase in extending the length of single-stranded telomeric: DNA. The anilino substituent at the 9-position of the acridine chromophore is predicted to lie in a third groove of the quadruplex. Calculated relative binding energies predict enhanced selectivity compared with earlier 3,6-disubstituted compounds, as a result of this substituent, The ranking order of energies is in accord with equilibrium binding constants for quadruplex measured by surface plasmon resonance techniques, which also show reduced duplex binding compared with the disubstituted compounds. The 3,6,9-trisubstututed acridines have potent in vitro inhibitory activity against human telomerase. with EC50 values of up to 60 nM.
URI
https://repository.icr.ac.uk/handle/internal/2871
DOI
https://doi.org/10.1073/pnas.081560598
Collections
  • Other ICR Research
Language
eng
License start date
2001-04-24
Citation
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 pp. 4844 - 4849

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.